William Desmarais - Jul 15, 2021 Form 3 Insider Report for TScan Therapeutics, Inc. (TCRX)

Role
Chief Business Officer
Signature
/s/ William Desmarais
Stock symbol
TCRX
Transactions as of
Jul 15, 2021
Transactions value $
$0
Form type
3
Date filed
7/15/2021, 06:24 PM
Next filing
Aug 31, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TCRX Employee Stock Option (right to buy) Jul 15, 2021 Voting Common Stock 120K $13.94 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option vest over 4 years of service following March 22, 2021, with 25% vesting upon completion of 1 year of continuous service to the Issuer and the balance vesting in 36 equal monthly installments thereafter.